BRCA2 and neoplasm: Some of the DDR biomarker-negative responders had shallow deletions of BRCA2. Given the responses, one hypothesis is that the shallow deletion in these responders reflects deep deletion in a subset of tumor cells rather than shallow deletion in all cells, as has been previously proposed [27].